AQP4 and myeloid sarcoma: This contrasts with the pathology in MS, where CD8+ T cells are predominant and chronic microglial activation occurs in chronically expanding lesion limbs, and in AQP4-NMOSD, which shows marked astrocyte loss and complement-mediated tissue necrosis [17].